Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 611 to 620 of 1966

TitleReference numberPublishedLast updated
Entecavir for the treatment of chronic hepatitis BTA153
Entrectinib for treating NTRK fusion-positive solid tumoursTA644
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancerTA643
Enzalutamide for hormone-relapsed non-metastatic prostate cancerTA580
Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimenTA316
Enzalutamide for treating hormone-sensitive metastatic prostate cancerTA712
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA377
Enzalutamide for treating non-metastatic prostate cancer after radical prostatectomy or radiotherapy (terminated appraisal)TA994
Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatmentsTA954
Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancerIPG784

Results per page

  1. 10
  2. 25
  3. 50
  4. All